Enthera
PrivateLast Round
Series A
Jan 28, 2021
Total Funding Raised
$47.1M
Company Overview
Enthera operates in Healthcare & Life Sciences and is based in Milan. Its latest recorded funding round was a Series A round in January 2021.
Enthera is a biopharmaceutical company that develops first-in-class biologics for the treatment of autoimmune disorders, including Type 1 Diabetes and Inflammatory Bowel Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enthera Comparables
Compare Enthera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Viridian Therapeutics | 78% | |
| EnteroTarget ApS | 78% | |
| Acelyrin | 77% |
For institutional investors. Book with your work email.
Enthera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 28, 2021 | ||||
| Seed | Jul 24, 2018 | ||||
| Seed | Nov 23, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enthera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Banca Profilo S.p.A. | Series A |
| Roche Venture Fund | Series A |
| Indaco Venture Partners SGR | Series A |
| AbbVie Ventures | Series A |
| Roche Venture Fund | Series A |
| JDRF | Seed, Series A |
| Sofinnova Partners | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2021
$42M round led by AbbVie Ventures, Roche Venture Fund, and Sofinnova Partners.
- Jul 24, 2018
$4.7M round led by Sofinnova Partners
For institutional investors. Book with your work email.
Enthera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enthera's valuation, stock price, and market status.
Is Enthera a public or private company?
Enthera is a private company.
What is the current stock price of Enthera?
Enthera is a private company, so its shares have no public market price. Caplight tracks Enthera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enthera worth (valuation)?
Valuation information for Enthera is not publicly available.
Can I buy Enthera stock?
Enthera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enthera's last funding round?
Enthera's most recent funding round was Series A on January 28, 2021.
Who are the main investors in Enthera?
Key investors in Enthera include AbbVie Ventures, Roche Venture Fund, Sofinnova Partners, BiovelocITA.
Will Enthera IPO soon?
No public IPO plans have been announced for Enthera.
How can I track Enthera secondary market activity?
Caplight tracks bids, offers, and trades in Enthera's shares on secondary markets.